ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Intesa Sanpaolo

Intesa Sanpaolo (I07602)

0.00
0.00
(0.00%)
Closed December 15 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

I07602 News

Official News Only
0 articles were found

Discussion

View Full Feed
badshah badshah 3 minutes ago
style="font-family: ".SFUI-Regular"; vertical-align: 1.5px"

RNVA
BigBadWolf BigBadWolf 4 minutes ago
Is this still in force / play. While I;try to pull court records. Appreciate any links that any could provide.
https://finance.yahoo.com/news/eyecity-com-inc-obtains-temporary-171700049.html
ICTY
Kool Aid Man Kool Aid Man 4 minutes ago
I'm also invested in OTC stocks..but via Fidelity's FOCPX portfolio. The difference is they don't buy pump-and-dump garbage like SPZI. Check their max chart

https://www.barchart.com/etfs-funds/quotes/FOCPX/overview
(compare w/ QQQ which has done better but likely overvalued at
QQQ SPZI
Peeteman Peeteman 5 minutes ago
What’s the data that no one else sees except you of course?
AXXA
Clark6290 Clark6290 5 minutes ago
Baseless claim
FNMA
rx7171 rx7171 6 minutes ago
Two stops.
First at 150 days for a max of two months.
The second at 180 days for a max of one month.
Total time of review 210 days PLUS time added for stops.
AVXL
ap17 ap17 9 minutes ago
EXACTLY!! well said. Stimulus money had ZERO to do with the last run, and will have less than zero to do with this one. Less than 2% of retail own XRP. Nice to see you back here. Cheers to all of us who held on 7+ YEARS, and welcome to the new believers. The doubters can go T a F of ARD.🏦&#
XRPUSD
Genz2 Genz2 10 minutes ago
Methinks, check out this post that I linked!! I guess you, Steven and I are maybe the only Wavoid’s left!! Don’t you think that Steven should put a lot more energy into the Wave cause given what he and his father Peter have put us through!!! If Peter, Steven and Michael could turn around National
SkyLimit2022 SkyLimit2022 12 minutes ago
ex,

Yes, it was unusual ..and the novel PIII-tested patent-fortified cell-based DCVax-L platform is also unusual…

The landmark PIII was exemplary, compassionate, and clinically appropriate. Following the PIII, the FDA approved another clinical trial to commence in whi
NWBO PIII
Doc logic Doc logic 12 minutes ago
exwannabe,

Yes a blinded efficacy analysis and DSMB look that ended with enrollment post screening halt only including treatment arm patients and only done to the point “statistically necessary” which left out 17 SOC/placebo patients and lowering the powering of the trial according to
NWBO
BigBadWolf BigBadWolf 13 minutes ago
Transfer Agent Verified
Share data displayed on www.otcmarkets.com alongside a "Transfer Agent Verified" logo has recently been verified by the company’s transfer agent as reliable and trustworthy. This data is also disseminated through OTC Markets Group's market data feeds to investors and b
ICTY
BDEZ BDEZ 13 minutes ago
Thanks for that Bob, going to watch it later.
BDEZ BDEZ 13 minutes ago
Yes he did Bob and should be punished...
BigBadWolf BigBadWolf 14 minutes ago
For my records Authorized Shares 10,000,000,000 12/11/2024
Outstanding Shares 7,232,965,438 12/11/2024
Restricted 910,989,212 12/11/2024
Unrestricted 6,321,976,226 12/11/2024
Held at DTC 3,943,567,296 12/11/2024
DTC
crazy horse 0 crazy horse 0 14 minutes ago
This is TRUE

https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/462185527_8317168844985694_3580612930057828743_n.jpg?_nc_cat=106&ccb=1-7&_nc_sid=0b6b33&_nc_ohc=v5_ZJX2lAP8Q7kNvgEghctQ&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AmrTxO43Vdrh7Q37ajULHz0&oh=00_AYDP1rq37AN_vFgaHAtgc7HDPNR
BDEZ BDEZ 14 minutes ago
Both states have too many rinos...
Lime Time Lime Time 14 minutes ago
On watch this week for volumes.
HMBL
Number sleven Number sleven 14 minutes ago
Skipper,
https://trovanorme.aifa.gov.it/#/ricerca-rapida/dettaglio/GU/24A06678?dataPubblicazione=2024-12-14T00:00:00Z
Sleven,
AMRN
Ecomike Ecomike 14 minutes ago
This:

"NFTM intends to acquire 100% of Strong AI’s share capital in exchange for ten million shares of NFTM common stock, valued at approximately $8 million. These shares will be issued in five installments over a 12-month period, contingent upon the achievement of key development mil
NFTM
lizzy241 lizzy241 15 minutes ago
RMB, after reading the review twice I agree the EMF risk factor is separate and requires additional research. They aren't disputing the R-I results. At least we know some progress is being made toward approval.
AMRN
morokoy morokoy 17 minutes ago
They have reached the pinnacle of journalism, "verifying the authenticity of rumors."
SMCI
Clj20 Clj20 17 minutes ago
Let's make a run!! Pump it 
MJLB
Doc logic Doc logic 18 minutes ago
RobotDroid,

I implore you not to take your frustration out on those pigs by taping wings on them and dropping them from your plane. We have already seen enough “hogwash” from shorts and “frustrated longs”; ). Best wishes.
NWBO
nwtf nwtf 20 minutes ago
Fact it you dont deal in facts so you cant respond with same.
ERHE

Your Recent History

Delayed Upgrade Clock